Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi | Paris | Healthcare | Pharmaceuticals | EUR 128.80B | 14.3x | 3.4 | EUR 102.68 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.4% Upside | Upgrade to Pro+ | |
Ipsen | Paris | Healthcare | Pharmaceuticals | EUR 9.81B | 14.6x | 0.29 | EUR 119.30 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.5% Upside | Upgrade to Pro+ | |
Virbac | Paris | Healthcare | Pharmaceuticals | EUR 2.66B | 18.9x | 1 | EUR 317.50 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.2% Upside | Upgrade to Pro+ | |
Vetoquinol | Paris | Healthcare | Pharmaceuticals | EUR 836.56M | 17.7x | -0.9 | EUR 70.70 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31% Upside | Upgrade to Pro+ | |
Medincell | Paris | Healthcare | Pharmaceuticals | EUR 467.08M | -14.8x | 1.64 | EUR 15.98 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44% Upside | Upgrade to Pro+ | |
Boiron | Paris | Healthcare | Pharmaceuticals | EUR 448.81M | 18.7x | -0.39 | EUR 25.85 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.1% Upside | Upgrade to Pro+ | |
Euroapi | Paris | Healthcare | Pharmaceuticals | EUR 305.03M | -1.3x | 0 | EUR 3.20 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.3% Downside | Upgrade to Pro+ | |
AB Science | Paris | Healthcare | Pharmaceuticals | EUR 98.52M | -12.8x | -0.25 | EUR 1.51 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DBV Technologies | Paris | Healthcare | Pharmaceuticals | EUR 90.35M | -0.8x | -1.35 | EUR 0.88 | 14.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aelis Farma | Paris | Healthcare | Pharmaceuticals | EUR 38.13M | -4.5x | 0.34 | EUR 2.80 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Advicenne | Paris | Healthcare | Pharmaceuticals | EUR 24.57M | -2.6x | -0.1 | EUR 2 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nicox | Paris | Healthcare | Pharmaceuticals | EUR 20.43M | -0.8x | EUR 0.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
SMAIO | Paris | Healthcare | Pharmaceuticals | EUR 16.01M | -14.2x | -0.92 | EUR 3.07 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valerio Therapeutics | Paris | Healthcare | Pharmaceuticals | EUR 11.96M | -0.6x | -0.02 | EUR 0.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharnext | Paris | Healthcare | Pharmaceuticals | EUR 34 | -0x | EUR 0.001 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |